Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
448
-
Total 13F shares, excl. options
-
73.4M
-
Shares change
-
-2.51M
-
Total reported value, excl. options
-
$22B
-
Value change
-
-$741M
-
Put/Call ratio
-
1.41
-
Number of buys
-
239
-
Number of sells
-
-195
-
Price
-
$300.28
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2014
528 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2014.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 448 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.4M shares
of 105M outstanding shares and own 69.92% of the company stock.
Largest 10 shareholders include Capital World Investors (7.63M shares), FMR LLC (5.74M shares), WELLINGTON MANAGEMENT CO LLP (4.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.1M shares), SANDS CAPITAL MANAGEMENT, LLC (4.01M shares), VANGUARD GROUP INC (3.91M shares), State Street Corp (3.25M shares), Artisan Partners Limited Partnership (3.24M shares), BlackRock Institutional Trust Company, N.A. (2.06M shares), and WELLS FARGO & COMPANY/MN (1.61M shares).
This table shows the top 448 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.